Dr.K. Kiran Kumar Radiation Oncologist in Hyderabad

Dr.K. Kiran Kumar

Radiation Oncologist, Hyderabad

MBBS, MD, DNB (Radiation Therapy)

  • 1 Hospital
  • Languages : English, Hindi, Telugu

Experience

Radiation Oncologist, Yashoda Hospitals, Hyderabad - Currently working here

Specialities

  • Radiation Oncology

Expertise

  • Advanced Techniques-SBRT
  •  Advanced Techniques-IMRT
  •  Advanced Techniques-IGRT
  • Accelerated Partial Breast Radiotherapy
  • Brachytherapy (Internal Radiation Therapy)
  •  External Beam Radiation For Prostate Cancer
  •  Radiation Oncologist
  •  Cancer Screening (Preventive)
  •  SBRT/SABR (Stereotactic Body Radiotherapy) for Cancerous Tumours
  •  Stereotactic Radiosurgery (SRS) for Brain & Spine Tumours
  •  External Beam Radiotherapy (EBRT) = Teleradiotherapy
  •  Image guided radiotherapy (IGRT)
  •  Hormone Therapy For Breast Cancer
  •  Hormone Therapy For Prostate Cancer
  •  Pap Smear

Education

  • MBBS, MD

Practice Information

Yashoda Hospitals, Somajiguda

Yashoda Hospitals, Somajiguda

Rajbhavan Road, Somajiguda, Hyderabad, Telangana - 500082

Achievements & Contributions

  • Principal investigator in Trial no 1200.161 - Trial title - A randomized, open-label, phase III study to evaluate the efficacy and safety of oral afatinib versus intravenous methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who have progressed after platinum-based therapy
  • Principal investigator trial numbers:1200:131 Trial title:LUX-Head and Neck 2:randomised, double blind, placebo-controlled, phase III study to evaluate the efficacy and safety of afatinib as adjuvant therapy after chemo-radiotherapy in primary unresected patients with stage III, IVa, or IVb loco-regionally advanced head and neck squamous cell carcinoma
  • Title NETU08-18: A phase III multicenter, randomized, double-blind, double-dummy,a ctive-controlled, parallel group study of the efficacy and safety of oral netupitant administered in combination with palonosetron and dexamethasone compared to oral palonosetron and dexamethasone for the prevention of nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy
  • Title NETU08-18: A phase III multicenter, randomized, double-blind, double-dummy,a ctive-controlled, parallel group study of the efficacy and safety of oral netupitant administered in combination with palonosetron and dexamethasone compared to oral palonosetron and dexamethasone for the prevention of nausea and vTitle:PALO10-01:Single dose, multicenter, randomized, double-blind, double-dummy,parallel group study to assess the efficacy and safety of oral palonosetron 0.50 mg compared to I.V palon
  • ARIO, IMA, ESMO

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr.K. Kiran Kumar and his staff know how they are doing and how they can improve their services.